Serum levels of 25-OH vitamin D, folic acid and testosterone in patients with breast cancer: a case control study

Fidan, Evren; Yildiz, Bulent; Ozdemir, Feyyaz; Ucar, Utku; Kavgaci, Halil; Orem, Asım; Aydin, Fazil

Serum levels of 25-OH vitamin D, folic acid and testosterone in patients with breast cancer: a case control study

Asian Biomedicine

Volume 5 (2011): Issue 5 (October 2011)

By:

Evren Fidan, Bulent Yildiz, Feyyaz Ozdemir, Utku Ucar, Halil Kavgaci, Asım Orem and Fazil Aydin

Open Access

|Feb 2017

References

1. Osborne JE, Hutchinson PE. Vitamin D and systemic cancer: is this relevant to malignant melanoma? Br J Dermatol. 2002; 147:197-213.
Search in Google Scholar Back to article
2. Colston KW. Vitamin D and breast cancer risk. Best Pract Res Clin Endocrinol Metab. 2008; 22:587-99.10.1016/j.beem.2008.08.002
Open DOI Search in Google Scholar Back to article
3. Ali MM, Vaidya V. Vitamin D and cancer. J Cancer Res Ther. 2007; 3:225-30.10.4103/0973-1482.38998
Open DOI Search in Google Scholar Back to article
4. Kim YI. Role of folate in colon cancer development and progression. J Nutr. 2003; 133: 3731-9.10.1093/jn/133.11.3731S
Search in Google Scholar Back to article
5. Choi SW, Mason JB. Folate status: effects on pathways of colorectal carcinogenesis. J Nutr. 2002; 132:2413-8.10.1093/jn/132.8.2413S
Search in Google Scholar Back to article
6. Kim YI. Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem.1999; 10:66-88.10.1016/S0955-2863(98)00074-6
Open DOI Search in Google Scholar Back to article
7. Graham S, Hellmann R, Marshall J, Freudenheim J, Vena J, Swanson M, et al. Nutritional epidemiology of postmenopausal breast cancer in western New York. Am J Epidemiol. 1991; 134:552-66.10.1093/oxfordjournals.aje.a116129
Search in Google Scholar Back to article
8. Hankinson SE, Eliassen AH. Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk. J Steroid Biochem Mol Biol. 2007; 106:24-30.10.1016/j.jsbmb.2007.05.012
Open DOI Search in Google Scholar Back to article
9. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition Endocr Relat Cancer. 2005; 12:1071-82.10.1677/erc.1.01038
Open DOI Search in Google Scholar Back to article
10. Green FL, Page DL, Fleming ID, editors. AJCC Cancer Staging Manuel. 6th ed. Newyork: Springer, 2002. p. 223-40.10.1007/978-1-4757-3656-4
Search in Google Scholar Back to article
11. Frampton RJ, Omond SA, Eisman JA. Inhibition of human cancer cell growth by 1,25-dihydroxyvitamin D3 metabolites. Cancer Res. 1983; 43:4443-7.
Search in Google Scholar Back to article
12. Chouvet C, Vicard E, Devonec M, Saez S. 1,25- Dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J Steroid Biochem. 1986; 24:373-6.10.1016/0022-4731(86)90085-3
Search in Google Scholar Back to article
13. Colston KW, Chander SK, Mackay AG, Coombes RC. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem Pharmacol. 1992; 44:693-702.10.1016/0006-2952(92)90405-8
Open DOI Search in Google Scholar Back to article
14. John EM, Schwartz GG, Dreon DM, Koo J. Vitamin D and breast cancer risk: the NHANES I Epidemiologic follow-up study, 1971-1975 to 1992. National Health and Nutrition Examination Survey. Cancer Epidemiol Biomarkers Prev. 1999; 8:399-406.
Search in Google Scholar Back to article
15. Palmieri C, MacGregor T, Girgis S, Vigushin D. Serum 25-hydroxyvitamin D levels in early and advanced breast cancer. J Clin Pathol. 2006; 59:1334-6.10.1136/jcp.2006.042747
Open DOI Search in Google Scholar Back to article
16. Mawer EB, Walls J, Howell A, Davies M, Ratcliffe WA, Bundred NJ. Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases. J Clin Endocrinol Metab. 1997; 82:118-22.10.1210/jc.82.1.118
Search in Google Scholar Back to article
17. Liao DJ, Dickson RB. Steroid hormone-growth factor interactions in proliferative controls of the mammary gland and breast cancer: a rapidly evolving perspective. J Steroid Biochem Mol Bio. 2002; 80: 135-6.10.1016/S0960-0760(01)00181-9
Open DOI Search in Google Scholar Back to article
18. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst. 2006; 98:1406-15.10.1093/jnci/djj37617018787
Open DOI Search in Google Scholar Back to article
19. Baggott JE, Vaughn WH, Juliana MM, Eto I, Krumdieck CL, Grubbs CJ. Effects of folate deficiency and supplementation on methylnitrosourea-induced rat mammary tumors. J Natl Cancer Inst. 1992; 84:1740-4.10.1093/jnci/84.22.17401433358
Open DOI Search in Google Scholar Back to article

DOI: https://doi.org/10.5372/1905-7415.0505.097 | Journal eISSN: 1875-855X | Journal ISSN: 1905-7415

Journal RSS Feed

Language: English

Page range: 663 - 667

Published on: Feb 4, 2017

Published by: Chulalongkorn University

In partnership with: Paradigm Publishing Services

Publication frequency: 6 issues per year

Keywords:

serum,

Related subjects:

Assistive professions, nursing,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Clinical medicine, other

© 2017 Evren Fidan, Bulent Yildiz, Feyyaz Ozdemir, Utku Ucar, Halil Kavgaci, Asım Orem, Fazil Aydin, published by Chulalongkorn University
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 5 (2011): Issue 5 (October 2011)Next article